Taking a Measure of MacArthur Prize

WASHINGTON—When Robert Coleman took the phone call, the University of California at Berkeley mathematician thought the official-sounding voice was a sales man. When he heard the words "MacArthur Foundation," he expected to be asked for a donation. But when program director Kenneth Hope told Coleman that he was one of 32 new MacArthur fellows and that he would receive $215,000 over the next five years, the message finally got through. By at least one measure, how ever, the 32-year-old Cole

Written byRon Cowen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

By at least one measure, how ever, the 32-year-old Coleman was justified in being surprised at his selection for what has been labeled the "genius award." Last year only two of his papers were cited a total of five times in papers by other re searchers, the lowest citation rate of any of this year's 16 scientists chosen by the foundation. But un like recipients of most other prestigious awards, MacArthur fellows do not always have the most distinguished publishing track records.

"We look for quality, not quantity," said associate director Paul Schullenberger. The awards are in-tended, he said, to encourage people "at the height of their creativity and productivity," and thus often go to younger and lesser-known scientists. (For a complete list of science winners, see Happenings.)

Harvard mathematician Eric Lander, who is two years younger than Coleman and whose work is also cited infrequently by other authors, said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies